[
    [
        {
            "time": "",
            "original_text": "复盘：91只涨停股谁能连板？两大顶级概念首次正面交锋！",
            "features": {
                "keywords": [
                    "涨停股",
                    "连板",
                    "顶级概念",
                    "正面交锋"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复盘：91只涨停股谁能连板？两大顶级概念首次正面交锋！",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 10,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "61股今日获机构买入评级",
            "features": {
                "keywords": [
                    "机构买入评级",
                    "股票数量"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "61股今日获机构买入评级",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "粤开证券 | 首席观点周荟萃：A股存在较丰富的结构性机会",
            "features": {
                "keywords": [
                    "粤开证券",
                    "首席观点",
                    "结构性机会"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "粤开证券 | 首席观点周荟萃：A股存在较丰富的结构性机会",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "【读财报】血液制品行业首份年报：卫光生物净利润1.7亿元，行业细分市场面临毛利下行压力",
            "features": {
                "keywords": [
                    "血液制品",
                    "卫光生物",
                    "净利润",
                    "毛利下行压力"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【读财报】血液制品行业首份年报：卫光生物净利润1.7亿元，行业细分市场面临毛利下行压力",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "晨会聚焦200309重点关注化工、长安汽车、电子、商贸零售、证券、医药、密尔克卫、上汽集团",
            "features": {
                "keywords": [
                    "晨会聚焦",
                    "化工",
                    "长安汽车",
                    "电子",
                    "商贸零售",
                    "证券",
                    "医药",
                    "密尔克卫",
                    "上汽集团"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "化工",
                    "汽车",
                    "电子",
                    "商贸零售",
                    "证券",
                    "医药",
                    "物流"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "晨会聚焦200309重点关注化工、长安汽车、电子、商贸零售、证券、医药、密尔克卫、上汽集团",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "卫光生物净利润1.7亿元 行业细分市场面毛利下行压力",
            "features": {
                "keywords": [
                    "卫光生物",
                    "净利润",
                    "毛利下行压力"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "卫光生物净利润1.7亿元 行业细分市场面毛利下行压力",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        }
    ]
]